Xencor (XNCR) Gains (Losses) on Sale of Assets & Investments (2015 - 2026)
Xencor (XNCR) posted Gains (Losses) on Sale of Assets & Investments of $18.06 million for Q2 2026, up 263.7% from $4.97 million a year earlier.
Powered by 
Analysis
Xencor (XNCR) Gains (Losses) on Sale of Assets & Investments (2015 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Gains (Losses) on Sale of Assets & Investments at Xencor was $61.74 million; for FY2025, it came in at $101.51 million.
- In prior years, Xencor's Gains (Losses) on Sale of Assets & Investments was -$31.42 million in FY2024, -$395,000 in FY2023, $23.43 million in FY2022 (-40.4%) and $39.29 million in FY2021.
- Quarterly Gains (Losses) on Sale of Assets & Investments has run from a low of -$51.93 million in Q1 2026 to a high of $51.41 million in Q4 2025 over five years.
- According to Business Quant data, Gains (Losses) on Sale of Assets & Investments for the three prior quarters was -$51.93 million (Q1 2026), $51.41 million (Q4 2025) and $44.2 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gains on Sales (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Xencor | 2.94 Bn | 1.37 Bn | - | 15.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 15.20 Mn |
| Jun 30, 2026 | 18.06 Mn |
| Mar 31, 2026 | -51.93 Mn |
| Dec 31, 2025 | 51.41 Mn |
| Sep 30, 2025 | 44.20 Mn |
| Jun 30, 2025 | 4.97 Mn |
| Mar 31, 2025 | 941,000.00 |
| Dec 31, 2024 | -30.97 Mn |
| Sep 30, 2024 | 9.25 Mn |
| Jun 30, 2024 | -12.03 Mn |
| Mar 31, 2024 | 2.33 Mn |
| Dec 31, 2023 | 13.24 Mn |
| Sep 30, 2023 | -11.02 Mn |
| Jun 30, 2023 | 1.80 Mn |
| Mar 31, 2023 | 3.33 Mn |
| Dec 31, 2022 | 31.83 Mn |
| Sep 30, 2022 | 5.30 Mn |
| Jun 30, 2022 | -6.55 Mn |
| Mar 31, 2022 | -5.61 Mn |
| Dec 31, 2021 | -18.22 Mn |
API Access
Xencor Gains (Losses) on Sale of Assets & Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=XNCR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-investment-income", "ticker": "XNCR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=XNCR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();